STERIS plc Stock
STERIS plc Stock
Our community is currently high on STERIS plc with 4 Buy predictions and 0 Sell predictions.
Pros and Cons of STERIS plc in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
M***** P*******
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of STERIS plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
STERIS plc | - | - | - | - | - | - | - |
Smith & Nephew plc | -0.040% | 4.085% | -3.698% | -19.616% | -6.165% | -31.582% | - |
Dentsply Sirona Inc. | -1.770% | 1.547% | -4.716% | -23.042% | -10.224% | -47.185% | -36.035% |
Dexcom Inc. | -0.260% | 2.726% | 4.559% | 14.907% | 15.113% | 50.297% | 394.646% |
Comments
STERIS plc (NYSE: STE) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $250.00 price target on the stock.
Show more
Ratings data for STE provided by MarketBeat
STERIS plc (NYSE: STE) is now covered by analysts at KeyCorp. They set an "overweight" rating and a $253.00 price target on the stock.
Show more
Ratings data for STE provided by MarketBeat
STERIS plc (NYSE: STE) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $250.00 price target on the stock.
Show more
Ratings data for STE provided by MarketBeat